Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

MFN Policy Shock Reshapes Pharma Market; Europe Launches Drop, Withdrawals Rise

A GlobalData analysis published on March 25, 2026 reports that the US Most Favored Nation (MFN) Policy is already reshaping pharmaceutical markets in Europe. The study shows a significant drop in drug launches and a rise in withdrawals after the
  • News
MFN Policy Shock Reshapes Pharma Market; Europe Launches Drop, Withdrawals Rise

GLP-1 Boom Is Reshaping Pharma Manufacturing — Faster Speed, Higher GMP Risk

A recent PharmaTimes analysis highlights how GLP-1 drugs are reshaping pharmaceutical manufacturing under intense time-to-market pressure and rising investment in production capacity, particularly in the US. The report shows that fragmented systems, regulatory tightening, and AI adoption are increasing hidden
  • News
GLP-1 Boom Is Reshaping Pharma Manufacturing — Faster Speed, Higher GMP Risk

FDA Real-Time Clinical Trials Shock Pharma Industry, Expose Hidden Compliance Risks Across Systems

The FDA has launched a real-time clinical trial monitoring initiative in the United States, enabling regulators to access live trial data to accelerate drug development and approval. Reported by PharmaVoice on May 13, 2026, the move highlights a growing shift
  • News
FDA Real-Time Clinical Trials Shock Pharma Industry, Expose Hidden Compliance Risks Across Systems

Calibration in Pharma Industry in 2026: Standards, Procedures, and GMP Compliance Requirements

This article explains how GMP certified supplements ensure safety, quality, and regulatory compliance through strict manufacturing controls. It also shows how inspectors evaluate systems and how consumers can identify trusted products in highly regulated supplement markets.
  • Blog, Quality Management System
Laboratory scene demonstrating cGMP certified facilities supplements with quality control documentation, supplement testing, and inspection-based safety procedures.

Tavneos in Crisis — FDA Accuses Amgen of Data Manipulation

The U.S. Food and Drug Administration (FDA) has escalated its regulatory dispute with Amgen over the autoimmune drug Tavneos, accusing the company of manipulating clinical trial data and moving toward potential market withdrawal. The case, centered on alleged data integrity
  • News
Tavneos in Crisis — FDA Accuses Amgen of Data Manipulation

GMP Certified Supplements in 2026: Safety Standards, Quality Assurance, and How to Identify Trusted Products

This article explains how GMP certified supplements ensure safety, quality, and regulatory compliance through strict manufacturing controls. It also shows how inspectors evaluate systems and how consumers can identify trusted products in highly regulated supplement markets.
  • Blog, Quality Management System
Laboratory scene demonstrating cGMP certified facilities supplements with quality control documentation, supplement testing, and inspection-based safety procedures.

Compliant Pharma Sites Fail Annex 1 Inspections, GMP Approval Is No Longer Enough

A recent industry analysis highlights that many pharmaceutical manufacturing sites still fail EU GMP Annex 1 inspections despite passing traditional GMP audits. Published on 15 May 2026 by industry analyst Dobrin Kolarov, the report shows that regulators now prioritize real-time
  • News
Compliant Pharma Sites Fail Annex 1 Inspections, GMP Approval Is No Longer Enough

Data in GMP in 2026: Data Integrity, Compliance Requirements, and Inspection Readiness Explained

This article explains how data in GMP is controlled across its lifecycle, focusing on pharmaceutical data integrity, audit trail review, and electronic records compliance. It highlights regulatory expectations under ALCOA+ principles, FDA guidance, and Annex 11 requirements for inspection readiness.
  • Blog, Validation and Qualification
Pharmaceutical laboratory scene showing digital systems and documentation processes related to GMP data integrity, audit trail review, and electronic records compliance under Annex 11 and 21 CFR Part 11 requirements.